DEVELOPMENT OF ALLELE-SPECIFIC PCR (AS-PCR) ASSAYS TO INVESTIGATE MAJOR HIV RESISTANCE MUTATIONS TO NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS (NRTIS) AND NON NUCLEOSIDE RT INHIBITORS (NNRTI).

被引：0
|
作者：
Formicola, R. [1 ]
Bestetti, A. [1 ]
Soria, A. [1 ]
Galli, L. [1 ]
Danise, A. [1 ]
Sala, S. [1 ]
Sampaolo, M. [2 ]
Galli, A. [1 ]
Gianotti, N. [1 ]
Clementi, M. [2 ]
Lazzarin, A. [1 ]
Castagna, A. [1 ]
Cinque, Paola [1 ]
机构：
[1] Univ Milan, Osped San Raffaele, Dipartimento Malattie Infett, I-20127 Milan, Italy
[2] Laboraf Osped San Raffaele, Milan, Italy
来源：
INFECTION | 2009年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：44 / 44
页数：1
相关论文
共 50 条
  • [31] Effect of dolutegravir in combination with Nucleoside Reverse Transcriptase Inhibitors (NRTIs) on people living with HIV who have pre-existing NRTI mutations
    Sorstedt, Erik
    Carlander, Christina
    Flamholc, Leo
    Hejdeman, Bo
    Svedhem, Veronica
    Sonnerborg, Anders
    Gisslen, Magnus
    Yilmaz, Aylin
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (05) : 733 - 738
  • [32] Subtype-specific differences in the development of accessory mutations associated with high-level resistance to HIV-1 nucleoside reverse transcriptase inhibitors
    Koning, F. A.
    Castro, H.
    Dunn, D.
    Tilston, P.
    Cane, P. A.
    Mbisa, J. L.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (06) : 1220 - 1236
  • [33] Development of allele-specific PCR and RT-PCR assays for clustered resistance genes using a potato late blight resistance transgene as a model
    Millett, B. P.
    Bradeen, J. M.
    THEORETICAL AND APPLIED GENETICS, 2007, 114 (03) : 501 - 513
  • [34] Nucleoside reverse transcriptase (RT) inhibitor-specific mutations within the HIV-1 pol gene selected with a non-nucleoside type RT inhibitor
    Kleim, JP
    Rosner, M
    Winkler, I
    Paessens, A
    Kirsch, R
    Hsiou, Y
    Arnold, E
    Riess, G
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, 1995, 10 : 3 - 3
  • [35] A multivariate analysis on non-nucleoside HIV-1 reverse transcriptase inhibitors and resistance induced by mutation
    Almerico, AM
    Lauria, A
    Tutone, M
    Diana, P
    Barraja, P
    Montalbano, A
    Cirrincione, G
    Dattolo, G
    QSAR & COMBINATORIAL SCIENCE, 2004, 22 (9-10): : 984 - 996
  • [36] Structure-enhanced methods in the development of non-nucleoside inhibitors targeting HIV reverse transcriptase variants
    Frey, Kathleen M.
    FUTURE MICROBIOLOGY, 2015, 10 (11) : 1767 - 1772
  • [37] Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in experienced patients
    Marcelin, A
    Roquebert, B
    Malet, I
    Wirden, M
    Simon, A
    Katlama, C
    Calvez, V
    ANTIVIRAL THERAPY, 2005, 10 : S98 - S98
  • [38] Relationship between mutations in HIV-1 RNase H domain and nucleoside reverse transcriptase inhibitors resistance mutations in experienced patients
    Marcelin, AG
    Roquebert, B
    Malet, I
    Wirden, M
    Simon, A
    Katlama, C
    Calvez, V
    ANTIVIRAL THERAPY, 2005, 10 (04) : S98 - S98
  • [39] Identification of reverse transcriptase mutations associated with HIV-1 drug resistance mainly against non-nucleoside reverse transcriptase inhibitors in treatment-naive patients
    Magiorkinis, E
    Paraskevis, D
    Lazanas, M
    Kiosses, VG
    Gargalianos, P
    Hatzakis, A
    AIDS, 1999, 13 (10) : 1276 - 1278
  • [40] Linear-response study on the binding affinity of non-nucleoside RT inhibitors with HIV-1 reverse transcriptase
    Sun, GY
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2005, 230 : U2611 - U2611
12345